Barclays »

Tevogen Bio Hldgs shares owned by Barclays

Quarter-by-quarter ownership of Tevogen Bio Hldgs (TVGN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Tevogen Bio Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Tevogen Bio Hldgs held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tevogen Bio Hldgs by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $45k 57k 0.79
2025-06-30 $86k 69k 1.26
2025-03-31 $41k 38k 1.08
2024-12-31 $48k 46k 1.05
2024-09-30 $13k 33k 0.40
2024-06-30 $5.0k 7.5k 0.66

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Tevogen Bio Hldgs

BlackRock
Vanguard Group
Geode Capital Management
Northern Trust
Morgan Stanley
Goldman Sachs Group
State Street Corporation
FMR
Sei Investments
Nuveen
Bridgeway Capital Management
Charles Schwab Investment Management
Barclays
Bank of New York Mellon
Creative Planning

View all funds holding Tevogen Bio Hldgs